RETA

Reata Pharmaceuticals, Inc. Class A Common Stock

Delisted

RETA was delisted on the 25th of September, 2023.

80 hedge funds and large institutions have $240M invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2017 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 30 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
$376K
Net Calls
Net Calls Change

Top Buyers

1 +$13.6M
2 +$12.1M
3 +$8.04M
4
Franklin Resources
Franklin Resources
California
+$7.78M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$6.87M

Top Sellers

1 -$1.11M
2 -$755K
3 -$254K
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$123K
5
CC
Capital Counsel
New York
-$117K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$27.9M
2
$20.9M
3
$18.4M
4
$17.7M
5
$16.1M
6
$14.7M
7
$12.1M
8
$7.78M
9
$7.78M
10
$7.11M
11
$6.38M
12
$6.35M
13
$6.22M
14
$5.91M
15
$5.81M
16
$4.97M
17
$4.43M
18
$4.1M
19
$2.98M
20
$2.83M
21
$2.81M
22
$2.59M
23
$2.46M
24
$2.26M
25
$2.17M